Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target.

Hao XuSongshan ChaiYihao WangJiajing WangDongdong XiaoJunjun LiNan-Xiang Xiong

Published in: CNS neuroscience & therapeutics (2020)

PARP9 may serve as an unfavorable prognosis predictor for glioma and a potential immunotherapeutic target.

Keyphrases